NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.4910
+0.0894 (22.26%)
Sep 4, 2026, 3:27 PM EDT - Market open
[Name] Stock Forecast
NRSN's stock price has decreased by -54.95% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, [Name] stock has a consensus rating of "Strong Buy" and an average price target of $6.50. The average 1-year stock price forecast is 1,223.83% higher than the current stock price, while the lowest is $3.00 (+511.00%) and the highest is $9.00 (+1,732.99%).
Price Target: $6.50 (+1,223.83%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for [Name] stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Noble Financial | Noble Financial | Buy Reiterates $9 | Buy | Reiterates | $9 | +1,732.99% | Aug 11, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $3 | Buy | Maintains | $3 | +511.00% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
4.04M
EPS This Year
-0.40
from -0.44
EPS Next Year
-0.82
from -0.40
EPS and Forward PE are based on non-GAAP adjusted numbers.